Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Back and forth in time: Directing age in iPSC-derived lineages.
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.
Gut commensalism, cytokines, and central nervous system demyelination.
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience.
Cannabinoids and autoimmune diseases: A systematic review.
Transfer of Methylprednisolone into Breast Milk in a Mother with Multiple Sclerosis.
Clinico-radiologic profile of spinal cord multiple sclerosis in adults.
An unusual case of 'itchy paralysis': neuromyelitis optica presenting with severe neuropathic itch.
The Role of fMRI to Assess Plasticity of the Motor System in MS.
Commentary: Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis.
A New Method to Segment the Multiple Sclerosis Lesions on Brain Magnetic Resonance Images.
Remyelination Therapy in Multiple Sclerosis.
The Stress-Buffering Effects of Hope on Adjustment to Multiple Sclerosis.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives.
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors which are anti-inflammatory when stimulated.
Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis.
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
CCRL2 regulates M1/M2 polarization during EAE recovery phase.
Disease exacerbation after rituximab induction in neuromyelitis optica.
Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica.
Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?
Blinded and unblinded internal pilot study designs for clinical trials with count data.
Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.
Pages
« first
‹ previous
…
623
624
625
626
627
628
629
630
631
…
next ›
last »